The MDA-MB-231 cell line was chosen based on prior research studying CCR5 and the ability of MDA-MB-231 cells to form both single-nucleus tumor cells and polyploid giant cancer cells (PGCCs) that can act as a theoretical model for both CTCs and CAMLs [22, 29–31]. This evidence concerns the gene CCR5 and neoplasm.